Current Pharmaceutical Design
Title:Recent Advances towards the Treatment of Depressive Disorders
Volume: 24 Issue: 22
Author(s): Kefeng Li and Xu Wang
Affiliation:
Export Options
About this article
Cite this article as:
Li Kefeng and Wang Xu , Recent Advances towards the Treatment of Depressive Disorders, Current Pharmaceutical Design 2018; 24 (22) . https://dx.doi.org/10.2174/138161282422181019144120
DOI https://dx.doi.org/10.2174/138161282422181019144120 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Progress in Gene Therapy for Parkinson’s Disease
Current Molecular Medicine Novel Targets for Drugs in Schizophrenia
CNS & Neurological Disorders - Drug Targets The Mediterranean and other Dietary Patterns in Secondary Cardiovascular Disease Prevention: A Review
Current Vascular Pharmacology A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Nanoparticle Therapy for Allergic and Inflammatory Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery Netrin and DCC: Axon Guidance Regulators at the Intersection of Nervous System Development and Cancer
Current Drug Targets Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review
Current Pharmaceutical Design Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke
Current Medicinal Chemistry Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry The Role of Matrix Metalloproteinases in Essential Hypertension
Current Topics in Medicinal Chemistry NAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric Diseases (Executive Editor: Luisa Minghetti) ]
Current Pharmaceutical Design Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders
Current Neuropharmacology Role of the Hippocampus and Amygdala in the Extinction of Fear- Motivated Learning
Current Neurovascular Research Cerebral Ischemia and Angiogenesis
Current Neurovascular Research Time-Controlled Pulsatile Delivery Systems for Bioactive Compounds
Recent Patents on Drug Delivery & Formulation Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications
Current Pharmaceutical Design APP Transgenic Mouse Models and their Use in Drug Discovery to Evaluate Amyloid-β Lowering Therapeutics
CNS & Neurological Disorders - Drug Targets Ethanol Metabolism and Effects: Nitric Oxide and its Interaction
Current Clinical Pharmacology